Differences and Explanation of Chronic Lymphocytic Leukemia (CLL) and Splenic Lymphoma with Villous Lymphocytosis (SLL)
Article Title: Understanding Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL): Two Sides of the Same Coin
Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL) are two types of indolent non-Hodgkin lymphoma that primarily affect older adults, with the median age of diagnosis being 68 years. These diseases, while distinct in their presentation, are believed to be two manifestations of the same cancer.
CLL: A Blood and Bone Marrow Affair
CLL primarily involves the bone marrow and blood, where the malignant B cells accumulate and circulate. It may also cause swollen lymph nodes, an enlarged spleen, or liver as the disease progresses, but it originates mainly in the bone marrow[1][5].
SLL: Lymph Nodes and Lymphatic System Dominance
On the other hand, SLL mainly affects the lymph nodes and lymphatic system without a significant presence in the blood or bone marrow at diagnosis. It is considered the same disease biologically as CLL but differs in the primary location of tumor cells—SLL presents as lymph node enlargement rather than leukemia in the blood[1][4].
To summarize, CLL is more active in the blood and bone marrow, while SLL primarily affects the lymph nodes and lymphatic system. Both diseases, however, are part of the lymphatic system, which is a crucial component of both the circulatory and immune systems.
Commonalities and Differences
Both CLL and SLL affect the lymphatic system and cause immature white blood cells to affect the immune system. In 50-75% of newly diagnosed cases, a person with CLL/SLL will have no symptoms[2].
The main difference between CLL and SLL is the part of the immune system the cancer affects. While CLL primarily involves the bone marrow and blood, SLL mainly affects the lymph nodes and lymphatic system.
Treatment Options
There is no cure for either SLL or CLL, but treatment can help improve a person's quality of life and slow the progression of the cancer. Treatment options for CLL and SLL may include watchful waiting, immunotherapy, radiation therapy, chemoimmunotherapy, targeted therapy, clinical trials, and stem cell transplant[3].
Doctors may also recommend additional treatment options for complications of the cancer, such as antibiotics to fight infections or treatment for symptoms like fatigue. The choice of treatment will depend on factors like age, overall health, symptoms, and stage of the cancer.
Staging Systems
The Rai staging system is used to classify CLL, with Stage 0 having near-normal red blood cell and platelet counts and no enlargement of the lymph nodes, spleen, or liver. Stage 1 involves an increased white blood cell count but near-normal red blood cell and platelet counts and enlarged lymph nodes[3].
Stage 2 of the Rai staging system involves an increased white blood cell count, an enlarged spleen, and possibly an enlarged liver and lymph nodes. Stage 3 has an increased white blood cell count with low red blood cell count and normal platelets. The lymph nodes, spleen, and liver may or may not be enlarged[3].
Stage 4 of the Rai staging system has an increased white blood cell count with low or almost normal red blood cell count and low platelets. The lymph nodes, spleen, and liver are enlarged[3].
CLL: The Most Common Leukemia in Adults
CLL is the most common type of leukemia in adults, accounting for most new diagnoses of non-Hodgkin lymphoma[2]. Despite its prevalence, advancements in treatment and understanding of these diseases continue to improve, offering hope for those affected by CLL and SLL.
[1] Cancer.net. (2021). Chronic Lymphocytic Leukemia (CLL) - Treatment (Cancer.net). [online] Available at: https://www.cancer.net/content/disease-information/chronic-lymphocytic-leukemia-cll/treatment
[2] Cancer Research UK. (2021). Chronic lymphocytic leukaemia (CLL). [online] Available at: https://www.cancerresearchuk.org/about-cancer/blood-cancers/chronic-lymphocytic-leukaemia-cll
[3] Lymphoma Research Foundation. (2021). Chronic Lymphocytic Leukemia (CLL) | Lymphoma Research Foundation. [online] Available at: https://lymphoma.org/chronic-lymphocytic-leukemia/
[4] National Cancer Institute. (2021). Small Lymphocytic Lymphoma (SLL) Treatment (PDQ®) - Health Professional Version. [online] Available at: https://www.cancer.gov/types/lymphoma/hp/sll-treatment-pdq
[5] American Cancer Society. (2021). Chronic lymphocytic leukemia (CLL). [online] Available at: https://www.cancer.org/cancer/chronic-lymphocytic-leukemia/about/what-is-cll.html
- Chronic Lymphocytic Leukemia (CLL), the most common cancer in the field of oncology, is primarily characterized by its impact on the bone marrow and blood.
- Small Lymphocytic Lymphoma (SLL), a type of chronic disease, mainly affects the lymph nodes and lymphatic system.
- Both CLL and SLL, being two sides of the same cancer, are part of the lymphatic system, a crucial component of the immune system.
- Despite being distinct in their initial locations, both CLL and SLL share a commonality: they cause immature white blood cells to affect the immune system.
- Lymphoma and chronic kidney disease are two different medical-conditions, but they are discussed in the science of lymphology and health-and-wellness as they are ailments that require extensive medical attention and management.
%20and%20Splenic%20Lymphoma%20with%20Villous%20Lymphocytosis%20(SLL)){kind=link}